Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Notification

18 Sep 2020 09:47

RNS Number : 4313Z
Scapa Group PLC
18 September 2020
 

18 September 2020

LEI No. 213800QIPVTK5ES5UU36

SCAPA GROUP PLC

('the Company')

 

Director/PDMR Notification

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR')

Scapa Group plc (AIM: SCPA) today announces that on 16 September 2020, the PDMRs named below were each granted nil cost options, under the Scapa Group plc 2019 Long Term Incentive Plan ('LTIP'), in respect of the number of ordinary shares of 5p each ('Ordinary Shares') shown alongside their respective names.

 Name / Position of PDMR

Number of Ordinary Shares over which the option is held

Oskar Zahn - Chief Financial Officer

300,172

John Petreanu - President Healthcare

254,113

Brett Pollard - MD Global Corporate Dev & Strategy

75,043

Wendy Baker - Group General Counsel and CoSec

145,798

In accordance with the rules of the LTIP, no consideration was paid by the above-named individuals for the option granted to him/her. Each option is subject to, and governed by, the rules of the LTIP and the legislation relating to the LTIP.

This announcement, including the notifications below, is made in accordance with the requirements of the EU Market Abuse Regulation.

ANNEX

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Oskar Zahn

 

2

Reason for the notification

 

a)

Position / status

Chief Financial Officer

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

300,172 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

16 September 2020

 

f)

Place of the transaction

Off Market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

John Petreanu

 

2

Reason for the notification

 

a)

Position / status

President, Healthcare

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

254,113 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

 

Off Market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Brett Pollard

 

2

Reason for the notification

 

a)

Position / status

MD, Global Corp Development & Strategy

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

75,043 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

 

Off Market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Wendy Baker

 

2

Reason for the notification

 

a)

Position / status

Group General Counsel and CoSec

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

145,798 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

Off Market

 

 

 

For further information:

 

Scapa Group plc:

Wendy Baker +44 (0) 161 301 7400

Company Secretary

 

Numis Securities Limited: +44 (0) 20 7260 1000

Mark Lander/Freddie Barnfield

(Joint Broker/Nominated Adviser)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUWSWRRSUKARR
Date   Source Headline
23rd Dec 20143:48 pmRNSHolding(s) in Company
10th Dec 20141:09 pmRNSHolding(s) in Company
2nd Dec 201410:00 amRNSDirectorate Change
1st Dec 201410:07 amRNSHolding(s) in Company
1st Dec 201410:03 amRNSHolding(s) in Company
26th Nov 20142:09 pmRNSAdditional Listing
25th Nov 20147:00 amRNSHalf Yearly Report
24th Nov 20149:08 amRNSHolding(s) in Company
18th Nov 20149:27 amRNSHolding(s) in Company
29th Oct 20143:33 pmRNSHolding(s) in Company
9th Oct 20147:00 amRNSTrading Statement
11th Aug 20147:00 amRNSDirector/PDMR Shareholding
7th Aug 20147:00 amRNSBlocklisting Interim Review
6th Aug 20149:03 amRNSDirector/PDMR Shareholding
23rd Jul 20147:00 amRNSDirector/PDMR Shareholding
22nd Jul 20145:04 pmRNSHolding(s) in Company
22nd Jul 20147:00 amRNSAGM Statement
11th Jun 20147:00 amRNSCompany Listing
9th Jun 20147:00 amRNSDirector/PDMR Shareholding
30th May 20143:44 pmRNSHolding(s) in Company
28th May 20147:00 amRNSFinal Results
16th May 20149:29 amRNSHolding(s) in Company
13th May 20143:08 pmRNSHolding(s) in Company
28th Apr 20144:20 pmRNSHolding(s) in Company-AMENDMENT
25th Apr 20142:58 pmRNSHolding(s) in Company
11th Apr 20149:45 amRNSHolding(s) in Company
10th Apr 20147:00 amRNSTrading Statement
3rd Apr 201410:24 amRNSAdditional Listing
13th Mar 20145:17 pmRNSHolding(s) in Company
12th Mar 20142:31 pmRNSAdditional Listing
6th Mar 20149:23 amRNSHolding(s) in Company
3rd Mar 20141:11 pmRNSHolding(s) in Company
18th Feb 20143:52 pmRNSHolding(s) in Company
7th Feb 20147:00 amRNSBlocklisting Interim Review
6th Feb 20147:00 amRNSMerger of UK Pension Schemes
29th Jan 20147:00 amRNSNew Finance Facility
9th Jan 20149:12 amRNSHolding(s) in Company
20th Dec 20138:42 amRNSHolding(s) in Company
11th Dec 20135:21 pmRNSHolding(s) in Company
11th Dec 20137:00 amRNSDirector/PDMR Shareholding
10th Dec 20137:00 amRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSHalf Yearly Report
25th Nov 20134:09 pmRNSHolding(s) in Company
5th Nov 201312:11 pmRNSHolding(s) in Company
10th Oct 20137:00 amRNSTrading Statement
27th Sep 20137:00 amRNSHolding(s) in Company
7th Aug 20134:52 pmRNSHolding(s) in Company
7th Aug 20138:57 amRNSBlocklisting Interim Review
26th Jul 20138:47 amRNSHolding(s) in Company
26th Jul 20138:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.